Italian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

lassa fever/febbre

Il collegamento viene salvato negli appunti
12 risultati

Small molecule inhibitors of ebola and lassa fever viruses

Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND Ebola virus (EboV) is a highly pathogenic enveloped virus that causes outbreaks of zoonotic infection in Africa. EboV is transmitted by close contact and virus levels increase by 75-fold/day for several days after initial infection. The clinical symptoms are manifestations of the massive

Small molecule inhibitors of ebola and lassa fever viruses and methods of use

Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND Ebolaviruses (EboV) are enveloped negative-sense RNA viruses that cause sporadic outbreaks of rapidly fatal zoonotic infection. EboV is transmitted by close contact and virus levels increase by 75-fold/day for several days after initial infection. The clinical symptoms are manifestations

Antiviral drugs for treatment of Arenavirus infection

Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION This invention relates to the use of benzimidazole derivatives and analogs, as well as compositions containing the same, for the treatment or prophylaxis of viral diseases associated with the arenavirus family such as Lassa fever, Argentine hemorrhagic fever, Bolivian

Antiviral drugs for treatment of arenavirus infection

Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION This invention relates to the use of benzimidaziole derivatives and analogs, as well as compositions containing the same, for the treatment or prophylaxis of viral diseases associated with the arenavirus family such as Lassa fever, Argentine hemorrhagic fever, Bolivian

Antiviral drugs for treatment of Arenavirus infection

Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION This invention relates to the use of benzimidazole derivatives and analogs, as well as compositions containing the same, for the treatment or prophylaxis of viral diseases associated with the arenavirus family such as Lassa fever, Argentine hemorrhagic fever, Bolivian

Antiviral drugs for treatment of arenavirus infection

Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION This invention relates to the use of benzimidazole derivatives and analogs, as well as compositions containing the same, for the treatment or prophylaxis of viral diseases associated with the arenavirus family such as Lassa fever, Argentine hemorrhagic fever, Bolivian

Antiviral drugs for treatment of arenavirus infection

Solo gli utenti registrati possono tradurre articoli
Entra registrati
FIELD OF THE INVENTION This invention relates to the use of benzimidazole derivatives and analogs, as well as compositions containing the same, for the treatment or prophylaxis of viral diseases associated with the arenavirus family such as Lassa fever, Argentine hemorrhagic fever, Bolivian

Host targeted inhibitors of dengue virus and other viruses

Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND OF THE INVENTION Dengue virus (DENV) is one of the most significant mosquito-borne viral infections affecting humans today and is an NIAID (National Institute of Allergy and Infectious Diseases) Category A Biodefense pathogen. DENV is a plus-stranded RNA virus and a member of the

Arenavirus receptor and methods of use

Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND OF THE INVENTION Certain arenaviruses are the causative agents of several severe and frequently fatal human hemorrhagic fevers. Among these pathogens, Lassa fever virus (LFV) produces high morbidity and mortality throughout West Africa. There are an estimated 250,000 persons infected by

Composition for treatment, inhibition and attenuation of virus

Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND Technical Field of Invention The present invention generally relates to pharmaceutical medication composition for the treatment of viral infections, and particularly to an pharmaceutical formulation for treatment, inhibition and attenuation of viruses in human beings Description of
SEQUENCE LISTING The sequence listing contained in the electronic file "2016-05-01 1464.8005_ST25.txt" created on May 2, 2016, comprising 60 KB is incorporated herein by reference". FIELD OF THE INVENTION This disclosure relates to rapid methods for real-time multiplex detection and identification

Method of treating Ebola

Solo gli utenti registrati possono tradurre articoli
Entra registrati
BACKGROUND Ebolaviruses (EboV) are enveloped negative-sense RNA viruses that cause sporadic outbreaks of rapidly fatal zoonotic infection. EboV is transmitted by close contact and virus levels increase by 75-fold/day for several days after initial infection. The clinical symptoms are manifestations
Unisciti alla nostra
pagina facebook

Il database di erbe medicinali più completo supportato dalla scienza

  • Funziona in 55 lingue
  • Cure a base di erbe sostenute dalla scienza
  • Riconoscimento delle erbe per immagine
  • Mappa GPS interattiva - tagga le erbe sul luogo (disponibile a breve)
  • Leggi le pubblicazioni scientifiche relative alla tua ricerca
  • Cerca le erbe medicinali in base ai loro effetti
  • Organizza i tuoi interessi e tieniti aggiornato sulle notizie di ricerca, sperimentazioni cliniche e brevetti

Digita un sintomo o una malattia e leggi le erbe che potrebbero aiutare, digita un'erba e osserva le malattie ei sintomi contro cui è usata.
* Tutte le informazioni si basano su ricerche scientifiche pubblicate

Google Play badgeApp Store badge